Hair Loss Was Just the Start. Ozempic Users Are Also Reporting Nail Trouble
3 hours ago
- GLP-1 medications like semaglutide and tirzepatide are associated with increased risk of hair loss and nail problems, particularly nail detachment.
- A study comparing 575 GLP-1 users to 1,379 controls found that about 50% of users reported unusual hair loss versus 33% of controls, and 39% of users reported nail detachment versus 9% of controls.
- Hair issues may not be solely due to weight loss, as scalp problems were not correlated with amount of weight lost.
- Nail problems were often linked to preexisting health conditions, skin issues, and nutritional deficiencies rather than direct drug effects.
- The FDA now requires GLP-1 drugs to list alopecia as a potential side effect on product labeling.
- Researchers advise patients not to stop treatment without consulting a doctor, as symptoms may be manageable without discontinuing the medication.